RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance.
Ray-David H; Romeo Y; Lavoie G; Déléris P; Tcherkezian J; Galan JA; Roux PP; Oncogene, 2013, vol. 32, issue 38, p 4480, ISSN 14765594. ISBN 14765594.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef